Skip to main content
Clinical Trials/NCT02567162
NCT02567162
Completed
N/A

Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage (MNEMONICH)

The University of Texas Health Science Center at San Antonio0 sites40 target enrollmentNovember 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Intracerebral Hemorrhage
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment
40
Primary Endpoint
Modified Rankin Scale score
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of this project is development of a comprehensive, prospective, multinational, multicenter, hospital-based, data repository for patients with intracerebral hemorrhage.

Detailed Description

MNEMONICH is a disease-specific registry of prospectively collected data obtained from the integration and harmonization of preexisting single-center data sets. It was formed to provide clinician-scientists around the world a comprehensive database to direct future studies toward better understanding of ICH. MNEMONICH will help examine global variability in the prevalence of ICH and identify research priorities. New data for MNEMONICH will be prospectively collected on a wide range of features including demographics, medical history, dates and times of symptom onset, presentation symptoms, hemodynamic signs, initial and chronic medical therapy, diagnostic imaging, laboratory and genetic analyses, pathological data, and surgical and medical management. Future research will be based upon ad hoc analysis of this data.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
August 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Reza Behrouz

Associate Professor

The University of Texas Health Science Center at San Antonio

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of spontaneous intracerebral hemorrhage (ICH) met by clinical and imaging criteria
  • Age 18 and above
  • Able to consent

Exclusion Criteria

  • ICH due to trauma
  • ICH due to vascular malformation or aneurysm
  • ICH due to brain tumor
  • ICH due to underlying infectious lesion (e.g., abscess)

Outcomes

Primary Outcomes

Modified Rankin Scale score

Time Frame: 90 days

Similar Trials